Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis

Correspondence to Dr Guo Yu, Clinical Medical College, Yangzhou University, Yangzhou 225009, China; guoyu@yzu.edu.cn The article by Lee et al 1 showed that the current use of proton pump inhibitors (PPIs) increased the risk of severe clinical outcomes of COVID-19 rather than the susceptibility to SA...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gut 2021-09, Vol.70 (9), p.1806-1808
Hauptverfasser:	Li, Guo-Fu, An, Xiao-Xiao, Yu, Yichao, Jiao, Li-Rong, Canarutto, Daniele, Yu, Guo, Wang, Guangji, Wu, Dan-Na, Xiao, Yin
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical decision making Clinical outcomes Coronaviruses COVID-19 Gastroenterology Gastroenterology & Hepatology Hypertension Infections Life Sciences & Biomedicine Pandemics PostScript Proton pump inhibitors Protons Science & Technology Sensitivity analysis Severe acute respiratory syndrome coronavirus 2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!